Sunday May 3, 2020
Topic: Testing and Tracing
Bio: Helped Implement the Affordable Care Act
From 2015-2017, Slavitt served as the Acting Administrator for the Centers for Medicare and Medicaid Services (CMS). In that role, he oversaw the Medicaid, Medicare, the Children’s Health Insurance Program, and the Health Insurance Marketplace programs. Slavitt’s tenure at CMS included shift to pay-for-value payment models, the implementation of the bipartisan MACRA legislation, and the Affordable Care Act.
Andy Slavitt QA
Topic: Innovative Solutions to Pandemics such as using community based disease monitoring using mobile phones
Bio: President of Ending Pandemics.
Since 2009, Mark has served as the Chief Medical Officer and Director of Global Health at the Skoll Global Threats Fund (SGTF), where he developed the Ending Pandemics in Our Lifetime Initiative in 2012. Prior to SGTF, Mark developed the Predict and Prevent Initiative at Google.org, as part of the starting team at Google’s philanthropic arm. Working with a team of engineers, Google Flu Trends (a project that had tremendous impact on the use of big data for disease surveillance) was created in partnership with the U.S. Centers for Disease Control. Mark has served as Vice President for Biological Programs at the Nuclear Threat Initiative, a public charity directed by CNN founder Ted Turner and former U.S. Senator Sam Nunn. Before NTI, he led an 18-member expert committee of the National Academy of Medicine on the 2003 landmark report “Microbial Threats to Health: Emergence, Detection, and Response.” Mark served as the sixth Luther Terry Fellow in Washington, D.C., in the Office of the U.S. Surgeon General and as an Epidemic Intelligence Officer with the U.S. Centers for Disease Control and Prevention.
Mark Smolinski QA
Topic: Opening up Universities during a Pandemic
Bio: President of Brown University
Chris Paxson QA
Topic: Will small colleges survive the pandemic?
Bio: Professor of Education at University of Pennsylvania
Reading Assignment: The College Stress Test: Tracking Institutional Futures across a Crowded Market – Read Chapter 7
Bob Zemsky QA
Topic: Pandemic preparedness
Bio: Beth Cameron is NTI’s vice president for global biological policy and programs.
Cameron previously served as the senior director for global health security and biodefense on the White House National Security Council (NSC) staff, where she was instrumental in developing and launching the Global Health Security Agenda and addressed homeland and national security threats surrounding biosecurity and biosafety, biodefense, emerging infectious disease threats, biological select agents and toxins, dual‐use research, and bioterrorism.
From 2010‐2013, Cameron served as office director for Cooperative Threat Reduction (CTR) and senior advisor for the Assistant Secretary of Defense for nuclear, chemical and biological defense programs. In this role, she oversaw implementation of the geographic expansion of the Nunn‐Lugar CTR program. For her work, she was awarded the Office of the Secretary of Defense Medal for Exceptional Civilian Service.
Beth Cameron QA
Dr. Lyle Berkowitz
Bio: Lyle Berkowitz, MD, FACP, FHIMSS is a primary care physician, a healthcare innovator, a futurist, a digital health expert and a serial entrepreneur with a passion for creating real world solutions which improve the quality and efficiency of the healthcare system for both patients and physicians.
Lyle Berkowitz QA
Topic: Medical Restructuring Post-Pandemic
Bio: He serves as Chairman of the Board of Exactcare, Inc., Pharmscript Inc., and Specialty Networks, Inc. He is also a Board member of Abode, Inc. Doug has been a Board Member and advisor to seven other private-equity-backed health care services companies during his career, including Genoa Healthcare, Inc. Cotiviti, Inc. Golden State Medical Supply and Theorem, Inc.
From 2001 through 2013, Doug served as the CEO of Managed Health Care Associates, Inc. (MHA). MHA is the largest Group Purchasing Organization in the country focused on alternate site/non-acute settings.
Doug is on the faculty at the Wharton Business School where, for the last 13 years, he has taught health care services to second year MBA students in the Health Care Management program. Doug has received the prestigious “Excellence in Teaching Award” on five separate occasions, naming him a top rated Professor as voted upon by Wharton students.
Topic: Pandemic and Sports
Bio: Casey Wasserman is the Chairman of LA 2028 and CEO of Wasserman, a leading sports and entertainment agency, which he founded in 2002. Wasserman also serves as President and CEO of the Wasserman Foundation, a private family foundation founded in 1952 by his grandparents, Lew and Edie Wasserman. The foundation is an innovator in the areas of education, health, arts and culture, service and global initiatives.
Casey Wasserman QA
Topic: Religious Adaptation to the Pandemic
Bio: Associate Professor of Sociology at NYU and author of Summoned
Iddo Tavory QA
Topic: Municipal Finance and the Pandemic
Bio: David A. Skeel, Jr. is the S. Samuel Arsht Professor of Corporate Law at the University of Pennsylvania Law School and Member of the Financial Oversight and Management Board of Puerto Rico
Questions for Speakers